Search Tag: clinical trials

Executive Health Management

Gilgamesh-pharma-wins-14m-grant-to-develop-safer-ibogaine-for-opioid-disorder

2024 14 Mar

  Grant to support IND-enabling toxicology and Phase 1/1b development of novel cardiac-safe ibogaine analog, GM-3009   Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company committed to developing best-in-class, rapid-acting treatments for mental health disorders, today announced that it has been awarded a multi-year $14 million grant...Read more

Executive Health Management

Trialbee-further-expands-leadership-team-with-new-vp-of-global-sales-jo-holton

2022 11 Oct

New Addition Drives Momentum While Revenues Grow 150% from Increased Demand for Trialbee’s Global Technology, Strategy and Services Trialbee, the leader in data and technology-based patient recruitment and enrollment for clinical trials, continues to expand its leadership team with the addition of industry enterprise sales veteran Jo Holton as...Read more

Executive Health Management

Florence-healthcare-welcomes-key-opinion-leaders-kristin-surdam-and-gunnar-esiason

2022 07 Sep

New leaders will focus on making clinical trials more efficient and accessible Florence Healthcare ™ announced that it has hired two key opinion leaders as part of its mission to make clinical trials more efficient and accessible. Kristin Surdam, MS, PMP, CCRC, will lead the company’s thought leadership team and efforts to engage sponsors...Read more

Executive Health Management

Outsourcing-in-clinical-trials-east-coast-2022

2022 24 Apr

Find Arena OCT Events on Social Media Read more

Executive Health Management

Nonsurgical-orthopaedic-options-often-equal-to-surgery

2022 07 Jan

University of Bristol researchers recently examined the outcomes of ten common orthopaedic operations, including knee, hip, shoulder, spine, and wrist surgeries. They found that surgical treatments were often no more effective than less invasive options like exercise, physical therapy, and pharmaceuticals. These surgical procedures often involve cost,...Read more

Executive Health Management

Design-flaws-of-covid-19-clinical-trials

2020 10 Jun

A review of the registered clinical trials of potential treatments for COVID-19 suggests that in many cases the trial design lacks features key to scientific value, such as the use of control groups and patient and clinician blinding.   You might also like: EMA Fast-Tracking Procedures for COVID-19 Medicines   The...Read more

Executive Health Management

Potential-covid-19-treatments-some-in-some-out

2020 27 May

The UK health ministry has announced that the antiviral drug remdesivir would be made available to selected COVID-19 patients while the World Health Organization (WHO) is putting the hydroxychloroquine/chloroquine arm within the COVID-19 Solidarity Trial on hold.   You may also like : From Hydroxychloroquine and Remdesivir to Plasma Administration...Read more

Executive Health Management

Eu-supports-clinical-trials-during-covid-19

2020 29 Apr

The European Commission has published ‘Guidance on the Management of Clinical Trials During the Covid-19 (Coronavirus) Pandemic’ to ensure continuation of clinical trials in the EU during the pandemic.   You may also like: COVID-19 for R&D: Blessing or Curse?   The recommendations are part of the EU efforts to find...Read more

Executive Health Management

Recovery-worlds-largest-covid-19-clinical-trial

2020 06 Apr

In the UK, the world’s largest clinical trial of potential coronavirus treatments, the Randomised Evaluation of COVID-19 Therapy trial ( RECOVERY ), is underway. It is aimed at assessing the effects of different treatments, including repurposed and novel drugs, on major outcomes in COVID-19.   You may also like : COVID-19 Will Revolutionise...Read more

Executive Health Management

Monitor-me-infographic

2019 26 Aug

An overview of mHealth and its application and implementation in healthcare. Read more

Executive Health Management

Reducing-risks-and-generating-economic-benefits-2

2019 26 Aug

Did you know that IV filtration in an intensive care unit (ICU) could help to reduce risks and generate economic benefits?   Introduction   Intravenous administration of fluids and drugs is an important part of patient care for the critically ill. However, the contamination of infusion solutions by particles is a largely unknown and underestimated...Read more

Executive Health Management

Outsourcing-in-clinical-trials-east-coast-2021-2

2021 25 May

POSTPONED TO 2021 DUE TO COVID-19 HEALTH CONCERNS  NEW DATES 25-26 MAY, 2021 Find Arena OCT Events on Social Media Read more

Executive Health Management

Outsourcing-in-clinical-trials-medical-devices-europe-2020

2020 05 Feb

Find Arena OTC (Outstanding Clinical Trial Series) on Social Media      Read more

Executive Health Management

Top-target-treatments-infographic

2019 22 May

Top target treatments and application of personalised medicine in healthcare Read more

Executive Health Management

Outsourcing-in-clinical-trials-east-coast-2019

2019 21 May

Find OCT on Social Media Read more

Executive Health Management

Physician-pharma-conflicts-of-interest-matter-to-clinical-trial-participants

2015 10 Mar

New research suggests that multiple sclerosis (MS) patients are interested in knowing the details of their physicians’ financial relationships with pharmaceutical companies, and that patients’ participation in clinical trials for new MS therapies may be influenced by such disclosures. The revelation of these potential conflicts of interest to clinical...Read more

Executive Health Management

Recommendations-for-clinical-studies-in-rare-cancers

2014 01 Nov

One out of every five new cancer patients is diagnosed with a rare cancer. However, the clinical evidence that is required to effectively treat these rare cancer patients is quite scarce. That is mainly because clinical trials require large number of patients, and as far as rare cancers are concerned, accruing such large numbers is difficult. That...Read more

Executive Health Management

Transparency-matters-new-ema-agreement

2014 16 Jun

The European Medicines Agency (EMA) has come to an agreement about its policy pertaining to the publication of clinical trial data, which will allow the agency to proactively share study results that are submitted with applications for marketing authorisation. The policy will enable academic and non-commercial researchers to download, save and print...Read more